YTENのチャート
YTENの企業情報
| symbol | YTEN |
|---|---|
| 会社名 | Yield10 Bioscience Inc （メタボリックス） |
| 分野（sector） | Basic Industries 素材 |
| 産業（industry） | Containers/Packaging |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 原材料・素材（Materials） |
| 概要 | 事業概要 イールド･バイオサイエンス(Yield10 Bioscience Inc)(旧名:Metabolix Inc.)は農業生物化学会社である。同社は世界的食料安全を強化する食品･飼料作物の作物収量にある改善のための破壊的技術の開発に従事する。同社は植物光合成エネルギー利用効率の基本的要素を改善する新たな方法発見、採種のために炭素を伝送する炭素代謝の能率的利用によってアマナズナ、カノラ、大豆及び穀物等の作物に開発された収量形質を改善する。同社は光合成における炭素固定能率の改善及び植物への転換を可能とする技術を開発する。同社はカナダのサスカチュワン州のサスカトゥーンにあるグリーンハウスを有する追加の農業科学施設を有する。 メタボリックスは、米国のバイオサイエンス企業。有機体で発生し、化学的にポリエステルに類似し、自然界に見られる生物高分子類に属するポリヒドロキシアルカノエ―ト(PHAs)に焦点を当てる。プラットフォ―ムは、PHAバイオポリマ―、バイオ工業化学物質、作物に分かれる。作物から再生可能な化学物質やバイオエネルギ―を作る。 Yield10 Bioscience, Inc. is an agricultural bioscience company developing crop innovations aligned with trends in global food security, social responsibility, and sustainability. The Company is using its 'Trait Factory,' a differentiated trait gene discovery platform including the 'GRAIN' big data mining trait gene discovery tool as well as the Camelina oilseed 'Fast Field Testing' system, to develop improved Camelina varieties to produce proprietary products, and to produce high value seed traits for the agriculture and food industries. The Company's goals are to efficiently develop and commercialize a high value crop products business based on superior varieties of Camelina for producing feedstock oils, nutritional oils, and PHA bioplastics. As a path toward commercialization of novel traits, Yield10 is pursuing a partnering approach with major agricultural companies to drive new traits into development for canola, soybean, corn, and other commercial crops. Yield10 is headquartered in Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon, Canada. |
| 本社所在地 | 19 Presidential Way Woburn MA 01801 USA |
| 代表者氏名 | Robert L. Van Nostrand ロバート・L・ヴァン・ノストランド |
| 代表者役職名 | Chairman of the Board Independent Director |
| 電話番号 | +1 617-583-1700 |
| 設立年月日 | 33756 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 20人 |
| url | www.metabolix.com |
| nasdaq_url | https://www.nasdaq.com/symbol/yten |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -9.04200 |
| 終値（lastsale） | 1.425 |
| 時価総額（marketcap） | 14266237.875 |
| 時価総額 | 時価総額（百万ドル） 13.82674 |
| 売上高 | 売上高（百万ドル） 0.67200 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 4.17274 |
| 当期純利益 | 当期純利益（百万ドル） -10.68400 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Yield10 Bioscience Inc revenues decreased 44% to $345K. Net loss decreased 3% to $4.7M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects General and administrative decrease of 13% to $2.7M (expense) Interest income net increase from $47K (expense) to $80K (income). |
YTENのテクニカル分析
YTENのニュース
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2022 Financial Results and Host a Conference Call on Tuesday, March 14, 2023 2023/03/08 13:32:00 GlobeNewswire
WOBURN, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its fourth quarter and full year 2022 financial results and provide a corporate update on Tuesday, March 14, 2023.
Why Yield10 Bioscience Stock Is Taking Off Thursday 2023/03/02 14:02:28 Benzinga
Yield10 Bioscience Inc (NASDAQ: YTEN ) shares are trading higher Thursday after the company signed a Memorandum of Understanding (MOU) with American Airlines Inc (NASDAQ: AAL ). What To Know: The two companies will collaborate in developing the value chain for Camelina as a low-carbon feedstock oil for sustainable aviation fuel (SAF). Camelina is an annual oilseed plant in the mustard family that is native … Full story available on Benzinga.com
Yield10 Bioscience to Present at the Third Annual Winter Wonderland - Best Ideas 2023 Virtual Conference on February 21, 2023 2023/02/16 18:30:00 Accesswire
WOBURN, MA / ACCESSWIRE / February 16, 2023 / Yield10 Bioscience, Inc. (NASDAQ:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, has been invited to present at the Third Annual Winter Wonderland - Best Ideas 2023 Virtual Conference, which is being held virtually on February 21 st through February 24 th , 2023. Yield10 CEO Oliver Peoples, Ph.D. is scheduled to present on Tuesday, February 21, 2023 at 1:30 pm ET in a fireside chat panel that will be hosted by Ben Klieve, CFA, Senior Research Analyst of Lake Street Capital Markets. Management will be available for one-on-one meetings with investors who are registered for the conference. The presentation will be webcast live and available for replay here . To receive additional information, request an invitation or to schedule a one-on-one meeting, please email angie.wright@issuerdirect.com . Investors can register here. About Yield10 Bioscience Yield10 Bioscience, Inc. is an agricultural bioscience company that is using its differentiated trait gene discovery platform, the "Trait Factory", to develop improved Camelina varieties to produce proprietary seed products, and to discover high value genetic traits for the agriculture and food industries.
Yield10, CN Energy among major Energy/Materials gainers, Sherwin-Williams leads losers 2023/01/26 19:06:25 Seeking Alpha
Gainers: Yield10 Bioscience (YTEN) +12%. CN Energy (CNEY) +11%
American Lithium, Yield10 among major Energy/Material gainers, Amyris leads losers 2023/01/24 19:16:44 Seeking Alpha
Gainers: American Lithium (AMLI) +13%. Yield10 Bioscience (YTEN) +10%
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday''s Mid-Day Session 2022/12/07 18:45:59 Benzinga
Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX ) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC met the primary endpoint. TransCode Therapeutics, Inc. (NASDAQ: RNAZ ) shares climbed 59.1% to $0.6679 after the company reported withdrawal of registration statement. BioVie Inc. (NASDAQ: BIVI ) gained 26.2% to $5.87. BioVie recently announced results from two Phase 2 trials assessing NE3107''s potential in Parkinson''s Disease (PD) and Alzheimer''s Disease (AD). Bit Brother Limited (NASDAQ: BTB ) climbed 23.1% to $0.4680. Vor Biopharma Inc. (NASDAQ: VOR ) climbed 21.4% to $5.22 after the company disclosed initial clinical data from VBP101, its Phase 1/2a multicenter, open-label, first-in-human study of tremtelectogene empogeditemcel or “trem-cel” (formerly VOR33) in patients with acute myeloid leukemia. Vor Bio also priced underwritten offering of 15.3 million shares of common stock at $4.30 per share.
Yield10 Bioscience, Inc. (YTEN) Q3 2022 Earnings Call Transcript 2022/11/15 02:48:07 Seeking Alpha
Yield10 Bioscience, Inc. (NASDAQ:NASDAQ:YTEN) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Lynne Brum – Vice President of Planning and Corporate…
Yield10 Bioscience, Inc. 2022 Q3 - Results - Earnings Call Presentation (NASDAQ:YTEN) 2022/11/14 23:26:03 Seeking Alpha
The following slide deck was published by Yield10 Bioscience, Inc.
Yield10 Bioscience Announces Third Quarter 2022 Financial Results 2022/11/14 21:02:00 GlobeNewswire
-Grower contracts in place for winter 2022/2023 -Development of herbicide tolerance traits in Camelina on track -Collaboration with Rothamsted Research for omega-3 technology extended through 2023
Yield10 Bioscience Q3 2022 Earnings Preview 2022/11/11 22:35:06 Seeking Alpha
Yield10 Bioscience (YTEN) is scheduled to announce Q3 earnings results on Monday, November 14th, after market close.The consensus EPS Estimate is -$0.66 and the consensus Revenue…
Yield10 Bioscience, Inc. (YTEN) Q3 2022 Earnings Call Transcript 2022/11/15 02:48:07 Seeking Alpha
Yield10 Bioscience, Inc. (NASDAQ:NASDAQ:YTEN) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Lynne Brum – Vice President of Planning and Corporate…
Yield10 Bioscience, Inc. 2022 Q3 - Results - Earnings Call Presentation (NASDAQ:YTEN) 2022/11/14 23:26:03 Seeking Alpha
The following slide deck was published by Yield10 Bioscience, Inc.
Yield10 Bioscience Announces Third Quarter 2022 Financial Results 2022/11/14 21:02:00 GlobeNewswire
-Grower contracts in place for winter 2022/2023 -Development of herbicide tolerance traits in Camelina on track -Collaboration with Rothamsted Research for omega-3 technology extended through 2023
Yield10 Bioscience Q3 2022 Earnings Preview 2022/11/11 22:35:06 Seeking Alpha
Yield10 Bioscience (YTEN) is scheduled to announce Q3 earnings results on Monday, November 14th, after market close.The consensus EPS Estimate is -$0.66 and the consensus Revenue…
Yield10 Bioscience to Announce Third Quarter 2022 Financial Results and Host a Conference Call on Monday, November 14, 2022 2022/11/07 13:30:00 GlobeNewswire
WOBURN, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its third quarter 2022 financial results and provide a corporate update on Monday, November 14, 2022.